Self-measurement of Blood Glucose and Continuous Glucose Monitoring - Is There Only One Future?

Heinemann, Lutz; Stuhr, Andreas; Brown, Adam; Freckmann, Guido; Breton, Marc D; Russell, Steven; Heinemann, Lutz

Heinemann, Lutz; Stuhr, Andreas; Brown, Adam; Freckmann, Guido; Breton, Marc D; Russell, Steven; Heinemann, Lutz.

Afiliação

Heinemann L; Science Consulting in Diabetes GmbH, Neuss, Germany.
Stuhr A; Ascensia Diabetes Care, NJ, US.
Brown A; Science Consulting in Diabetes GmbH, Neuss, Germany.
Freckmann G; Ascensia Diabetes Care, NJ, US.
Breton MD; Head of Diabetes Technology and Digital Health Close Concerns, San Francisco, US.
Russell S; MD, General Manager and Medical Director, Institute of Diabetes Technology Research and Development Company GmbH ULM University, Germany.
Heinemann L; PhD, Associate Professor, Center for Diabetes Technologies, University of Virginia, US.

Eur Endocrinol ; 14(2): 24-29, 2018 Sep.

Article em En | MEDLINE | ID: mdl-30349591

Palavras-chave

Automated insulin dosing (AID) system; continuous glucose monitoring (CGM); mean absolute relative difference (MARD); self-monitoring of blood glucose (SMBG)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Eur Endocrinol Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google